Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
6791.60Today’s High
6966.0052W low
5205.6052W High
6966.00Open Price
6889.00Prev. Close
5890.9500Volume
422278.00Value
2904702564.70Fundamentals
Market Cap
114756.30
Price to Earnings
20.60
Price to Book Value
4.10
Dividend Yield
0.60
PE to Growth
0.90
Op Revenue TTM
28011.10
Net Profit TTM
5577.90
Cash From Operating Activity
4543.30
Return on Equity %
19.74
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
26 Jul, 2024
52.8
Week
56.1
Month
52.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
6878.75
PIVOT
First Resistance
6965.90
Second Resistance
7053.15
Third Resistance
7140.30
First Support
6791.50
Second Support
6704.35
Third Support
6617.10
Relative Strength Index
72.58
Money Flow Index
83.22
MACD
181.26
MACD Signal
171.84
Average True Range
139.91
Average Directional Index
37.89
Rate of Change (21)
13.32
Rate of Change (125)
21.22
Commodity Channel Index
123.9
Williams %R
-16.3
BETA
1 Month
0.33
3 Month
0.34
1 Year
0.38
3 Year
0.03
PRICE CHANGE ANALYSIS
↑ 3.66%
1 Week
Low
High
6580
6966
↑ 13.32%
1 Month
Low
High
5995
6966
↑ 10.02%
3 Months
Low
High
5600
6966
↑ 17.47%
6 Months
Low
High
5600
6966
↑ 25.62%
1 Year
Low
High
5205.55
6966
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 5317.50 | 4330.60 | 5061.80 | 5670.90 | 4668.80 | 3949.00 | 4998.30 | 4034.00 | 3783.40 | 3542.60 | 3941.50 | 3619.70 | 3432.30 | |
| Operating Expenses Qtr | 3700.20 | 3446.70 | 3209.60 | 3209.60 | 3488.80 | 3221.50 | 3077.50 | 3051.10 | 2989.00 | 2865.60 | 3075.10 | 2871.60 | 2747.80 | |
| Operating Profit Qtr | 1378.60 | 656.30 | 1629.10 | 2227.70 | 1061.10 | 675.10 | 1802.80 | 579.50 | 669.90 | 614.00 | 748.30 | 561.90 | 602.90 | |
| EBIDT Qtr Cr | 1591.30 | 883.90 | 1852.20 | 2461.30 | 1175.90 | 726.50 | 1920.80 | 982.90 | 784.60 | 677.00 | 866.40 | 748.10 | 684.50 | |
| Depreciation Qtr | 246.20 | 246.40 | 245.80 | 237.20 | 236.70 | 238.80 | 226.20 | 221.50 | 205.20 | 205.40 | 206.60 | 197.10 | 210.70 | |
| Net Profit Qtr | 1034.80 | 475.20 | 1192.60 | 1639.40 | 672.40 | 324.60 | 1116.30 | 499.50 | 419.70 | 341.10 | 449.00 | 413.40 | 311.50 | |
| Basic EPS Qtr | 62.14 | 28.55 | 71.68 | 98.66 | 40.49 | 19.54 | 67.25 | 30.10 | 25.29 | 20.55 | 27.07 | 24.94 | 18.78 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 20346.10 | 17553.80 | 14887.20 | 14150.20 | 12593.60 | |
| Operating Expenses Annual Cr | 13557.40 | 12747.70 | 11811.10 | 10212.30 | 8980.80 | |
| Operating Profit Annual | 5926.40 | 4214.80 | 2594.10 | 3136.80 | 2869.60 | |
| Operating Profit Margin Annual % | 29.13 | 24.01 | 17.43 | 22.17 | 22.79 | |
| Total Expenses Annual Cr | 14554.80 | 13687.80 | 12663.40 | 11094.00 | 9817.80 | |
| EBIDT Annual Cr | 6788.70 | 4806.10 | 3076.10 | 3937.90 | 3612.80 | |
| EBIDT Annual margin % | 33.37 | 27.38 | 20.66 | 27.83 | 28.69 | |
| Depreciation | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 | |
| PAT Before ExtraOrdinary Items Annual Cr | 4342.00 | 2612.80 | 1623.20 | 2186.40 | 2937.70 | |
| Net Profit Annual | 4342.00 | 2612.80 | 1623.20 | 2186.40 | 2937.70 | |
| Basic EPS Annual | 260.95 | 157.37 | 97.85 | 131.84 | 177.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 24240.80 | 20474.20 | 18336.20 | 16983.70 | 15191.90 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 580.40 | 460.90 | 114.30 | 85.60 | 103.40 | |
| Total Current Liabilities Annual Cr | 5538.10 | 4439.70 | 6045.10 | 4560.30 | 4180.50 | |
| Total Capital Plus Liabilities Annual Cr | 30359.30 | 25374.80 | 24495.60 | 21629.60 | 19475.80 | |
| Fixed Assets Annual | 8800.10 | 8119.70 | 7350.80 | 6745.10 | 4845.70 | |
| Total Non Current Assets Annual | 12543.40 | 11586.50 | 11012.00 | 10685.40 | 9369.10 | |
| Total Current Assets Annual | 17815.90 | 13788.30 | 13483.60 | 10944.20 | 10106.70 | |
| Total Assets Annual | 30359.30 | 25374.80 | 24495.60 | 21629.60 | 19475.80 | |
| Contingent Liabilities plus Commitments Annual Cr | 1763.60 | 830.20 | 827.40 | 1062.80 | 1068.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 3449.70 | 5052.90 | 1338.70 | 3514.20 | 1839.20 | |
| Cash from Investing Activity Annual | -3430.30 | -3447.60 | -2038.00 | -1458.00 | -1689.20 | |
| Cash from Financing Annual Activity | 68.10 | -2696.90 | 505.50 | -794.30 | -224.10 | |
| Net Cash Flow Annual | 87.50 | -1091.60 | -193.80 | 1261.90 | -74.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 1453.29 | 1228.94 | 1101.93 | 1020.65 | 914.07 | |
| ROE Annual % | 17.91 | 12.76 | 8.85 | 12.87 | 19.33 | |
| ROCE Annual % | 23.41 | 18.54 | 12.25 | 18.17 | 18.46 | |
| Total Debt to Total Equity Annual | 0.03 | 0.00 | 0.12 | 0.07 | 0.07 | |
| EBDIT Annual Margin % | 34.84 | 28.33 | 21.35 | 29.49 | 30.48 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 7311.30 | 7453.00 | 7217.60 | 6931.90 | 6453.70 | 6848.50 | 6372.60 | 6086.80 | 5596.80 | 5394.10 | 5992.40 | 5053.00 | 4850.80 | |
| Operating Expenses Qtr | 5299.90 | 5213.70 | 4888.80 | 4694.70 | 4727.30 | 4837.90 | 4430.40 | 4291.70 | 4282.00 | 4117.90 | 4427.10 | 4210.60 | 3713.50 | |
| Operating Profit Qtr | 1831.20 | 2023.10 | 2008.30 | 2062.10 | 1533.90 | 1938.50 | 1898.90 | 941.20 | 451.00 | 1215.70 | 1359.80 | 734.50 | 1053.20 | |
| EBIDT Qtr Cr | 2028.70 | 2239.30 | 2323.30 | 2236.10 | 1672.40 | 1997.20 | 1939.70 | 1795.10 | 572.90 | 1271.50 | 1565.30 | 842.40 | 1135.80 | |
| Depreciation Qtr | 367.70 | 373.50 | 375.50 | 353.30 | 315.50 | 323.70 | 309.20 | 301.80 | 293.00 | 294.20 | 294.10 | 283.90 | 308.80 | |
| Net Profit Qtr | 1309.80 | 1380.90 | 1482.20 | 1405.00 | 960.10 | 1243.90 | 1114.20 | 1189.00 | 97.00 | 709.30 | 995.80 | 380.40 | 557.30 | |
| Basic EPS Qtr | 78.66 | 82.94 | 89.09 | 84.55 | 57.79 | 74.91 | 67.13 | 71.64 | 5.84 | 42.75 | 60.03 | 22.95 | 33.61 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 28905.40 | 25725.20 | 22029.60 | 19338.90 | 18137.60 | |
| Operating Expenses Annual Cr | 20078.00 | 18320.70 | 17777.50 | 15177.60 | 15046.60 | |
| Operating Profit Annual | 7933.10 | 6349.00 | 3767.70 | 3869.90 | 2470.40 | |
| Operating Profit Margin Annual % | 27.45 | 24.68 | 17.10 | 20.01 | 13.62 | |
| Total Expenses Annual Cr | 21719.10 | 19713.70 | 19038.50 | 16503.40 | 16308.00 | |
| EBIDT Annual Cr | 8827.40 | 7404.50 | 4252.10 | 4161.30 | 3091.00 | |
| EBIDT Annual margin % | 30.54 | 28.78 | 19.30 | 21.52 | 17.04 | |
| Depreciation | 1470.00 | 1250.20 | 1165.20 | 1228.80 | 1163.10 | |
| PAT Before ExtraOrdinary Items Annual Cr | 5563.20 | 4470.30 | 2112.20 | 1903.60 | 1969.90 | |
| Net Profit Annual | 5577.90 | 4507.30 | 2182.50 | 1951.60 | 2026.00 | |
| Basic EPS Annual | 335.22 | 271.47 | 131.21 | 117.34 | 121.99 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 28254.80 | 23286.10 | 19212.40 | 17641.70 | 15598.80 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 1021.00 | 426.90 | 768.70 | 871.30 | 412.40 | |
| Total Current Liabilities Annual Cr | 9588.00 | 8572.10 | 9765.80 | 8103.80 | 7214.10 | |
| Total Capital Plus Liabilities Annual Cr | 38863.80 | 32285.10 | 29746.90 | 26616.80 | 23225.30 | |
| Fixed Assets Annual | 11294.80 | 9701.80 | 8867.60 | 9210.90 | 7894.10 | |
| Total Non Current Assets Annual | 14058.50 | 11859.60 | 11964.60 | 12066.50 | 10626.20 | |
| Total Current Assets Annual | 24805.30 | 20425.50 | 17782.30 | 14550.30 | 12599.10 | |
| Total Assets Annual | 38863.80 | 32285.10 | 29746.90 | 26616.80 | 23225.30 | |
| Contingent Liabilities plus Commitments Annual Cr | 2091.80 | 997.40 | 936.80 | 1077.40 | 1040.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 4543.30 | 5887.50 | 2810.80 | 3570.30 | 2984.10 | |
| Cash from Investing Activity Annual | -4028.30 | -4137.30 | -2638.70 | -2266.00 | -492.30 | |
| Cash from Financing Annual Activity | -376.30 | -2686.10 | -242.20 | -29.80 | -2515.90 | |
| Net Cash Flow Annual | 138.70 | -935.90 | -70.10 | 1274.50 | -24.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 1693.93 | 1397.72 | 1154.59 | 1060.20 | 938.56 | |
| ROE Annual % | 19.74 | 19.35 | 11.35 | 11.06 | 12.98 | |
| ROCE Annual % | 25.13 | 25.95 | 15.44 | 15.84 | 12.04 | |
| Total Debt to Total Equity Annual | 0.06 | 0.05 | 0.16 | 0.15 | 0.11 | |
| EBDIT Annual Margin % | 31.51 | 30.01 | 19.73 | 21.84 | 17.64 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC TRUSTEE COMPANY LTD. A/C HDFC NIFTY 50 ETF | 1.75 | 89016255 | - | - |
| ICICI PRUDENTIAL VALUE DISCOVERY FUND | 1.17 | 89016257 | - | - |
| NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2 | 2.53 | 89016263 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| G V PRASAD | 11.52 | 89016238 | 0 | 0 |
| SATISH REDDY KALLAM | 9.61 | 89016239 | 0 | 0 |
| KALLAM SATISH REDDY HUF | 3.31 | 89016240 | 0 | 0 |
| GUNUPATI VENKATESWARA PRASAD HUF | 1.52 | 89016241 | 0 | 0 |
| SAMRAJYAM REDDY KALLAM | 0.67 | 89016242 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC TRUSTEE COMPANY LTD. A/C HDFC NIFTY 50 ETF | 1.75 | 89016255 |
| SBI NIFTY INDEX FUND | 1.29 | 89016256 |
| ICICI PRUDENTIAL VALUE DISCOVERY FUND | 1.17 | 89016257 |
| MIRAE ASSET NIFTY INDIA MANUFACTURING ETF | 1.11 | 89016258 |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C-NIPPON INDIA NIFTY 50 VALUE 20 INDEX FUND | 1.02 | 89016259 |
| FIRST SENTIER INVESTORS ICVC - STEWART INVESTORS ASIA PACIFIC LEADERS SUSTAINABILITY FUND | 2.32 | 89016269 |
| LIFE INSURANCE CORPORATION OF INDIA P & GS FUND | 5.52 | 89016261 |
| J P Morgan Chase Bank NA | 14.59 | 89016266 |
| NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2 | 2.53 | 89016263 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 16, 2024 | 40 | FINAL | - | Equity Share |
| Jul 11, 2023 | 40 | FINAL | - | Equity Share |
| Jul 11, 2022 | 30 | FINAL | - | Equity Share |
| Jul 09, 2021 | 25 | FINAL | - | Equity Share |
| Jul 13, 2020 | 25 | FINAL | - | Equity Share |
| Jul 15, 2019 | 20 | FINAL | - | Equity Share |
| Jul 16, 2018 | 20 | FINAL | - | Equity Share |
| Jul 17, 2017 | 20 | FINAL | - | Equity Share |
| Jul 18, 2016 | 20 | FINAL | - | Equity Share |
| Jul 10, 2015 | 20 | FINAL | - | Equity Share |
| Jul 11, 2014 | 18 | FINAL | - | Equity Share |
| Jul 12, 2013 | 15 | FINAL | - | Equity Share |
| Jun 28, 2012 | 13.75 | FINAL | - | Equity Share |
| Jun 30, 2011 | 11.25 | FINAL | - | Equity Share |
| Jul 02, 2010 | 11.25 | FINAL | - | Equity Share |
| Jul 03, 2009 | 6.25 | FINAL | - | Equity Share |
| Jul 04, 2008 | 3.75 | FINAL | - | Equity Share |
| Jul 06, 2007 | 3.75 | FINAL | - | Equity Share |
| Jul 07, 2006 | 5 | FINAL | - | Equity Share |
| Jul 07, 2005 | 5 | FINAL | - | Equity Share |
| Jul 13, 2004 | 5 | FINAL | - | Equity Share |
| Aug 08, 2003 | 5 | FINAL | - | Equity Share |
| Aug 08, 2002 | - | FINAL | - | Equity Share |
| Nov 08, 2001 | - | INTERIM | Nov 26, 2001 | Equity Share |
| Jun 18, 2001 | - | FINAL | - | Equity Share |
| Sep 07, 2000 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Oct 10, 2001 | 10:5 | 2001-10-25 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jul 27, 2024 | Quarterly Results & Stock Split | - |
| May 07, 2024 | Audited Results & Final Dividend | - |
| Jan 30, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 26, 2023 | Quarterly Results | - |
| May 10, 2023 | Audited Results & Final Dividend | - |
| Jan 25, 2023 | Quarterly Results | - |
| Oct 28, 2022 | Quarterly Results | - |
| Jul 28, 2022 | Quarterly Results | - |
| May 19, 2022 | Audited Results & Final Dividend | - |
| Jan 28, 2022 | Quarterly Results | - |
| Oct 29, 2021 | Quarterly Results | - |
| Jul 27, 2021 | Quarterly Results | - |
| May 14, 2021 | Audited Results & Final Dividend | - |
| Jan 29, 2021 | Quarterly Results | - |
| Oct 28, 2020 | Quarterly Results | - |
| Jul 29, 2020 | Quarterly Results | - |
| May 20, 2020 | Audited Results & Final Dividend | (Revised) |
| May 13, 2020 | Audited Results & Final Dividend | - |
| Mar 27, 2020 | Others | Inter alia, to consider and approve Raising of funds through issuance of Commercial Papers. |
| Jan 27, 2020 | Quarterly Results | - |
| Nov 01, 2019 | Quarterly Results | - |
| Jul 29, 2019 | Quarterly Results | - |
| May 17, 2019 | Audited Results & Final Dividend | - |
| Feb 01, 2019 | Quarterly Results | - |
| Oct 26, 2018 | Quarterly Results | - |
| Jul 26, 2018 | Quarterly Results | - |
| May 22, 2018 | Audited Results & Dividend | - |
| Jan 25, 2018 | Quarterly Results | - |
| Oct 31, 2017 | Quarterly Results | - |
| Jul 27, 2017 | Quarterly Results | - |
| May 12, 2017 | Audited Results & Dividend | - |
| Feb 04, 2017 | Quarterly Results | - |
| Oct 25, 2016 | Quarterly Results | - |
| Jul 26, 2016 | Quarterly Results | - |
| May 12, 2016 | Audited Results & Dividend | - |
| Feb 17, 2016 | Buy Back of Shares | - |
| Feb 09, 2016 | Quarterly Results | - |
| Oct 29, 2015 | Quarterly Results | - |
| Jul 30, 2015 | Quarterly Results | - |
| May 12, 2015 | Audited Results & Final Dividend | - |
| Jan 29, 2015 | Quarterly Results | - |
| Oct 29, 2014 | Quarterly Results | - |
| Jul 30, 2014 | Quarterly Results | - |
| May 13, 2014 | Audited Results & Dividend | - |
| Feb 11, 2014 | Quarterly Results | - |
| Oct 31, 2013 | Quarterly Results | - |
| Jul 30, 2013 | Quarterly Results | - |
| May 14, 2013 | Audited Results & Dividend | - |
| Feb 14, 2013 | Quarterly Results | - |
| Oct 30, 2012 | Quarterly Results | - |
| Jul 19, 2012 | Quarterly Results | - |
| May 11, 2012 | Audited Results & Dividend | - |
| Feb 03, 2012 | Quarterly Results | - |
| Oct 25, 2011 | Quarterly Results | - |
| Jul 20, 2011 | Quarterly Results | - |
| May 13, 2011 | Audited Results & Dividend | - |
| Jan 25, 2011 | Quarterly Results | - |
| Oct 23, 2010 | Quarterly Results | - |
| Jul 22, 2010 | Quarterly Results | - |
| May 06, 2010 | Audited Results, Dividend & ESOP | To grant of 16,800 stock options, exercisable at par value of Rs. 5/- to the Independent Directors of the Co. under "Dr. Reddy's ESOS, 2002" & "Dr. Reddy's Employees ADR Stock Option Scheme, 2007". |
| Mar 31, 2010 | Issuance of Bonus Debentures | For issuance of bonus debentures to Shareholders of the Co. from its General Reserves built from undistributed profits, The allotment of debentures will account for an amount not exceeding Rs. 520 Cr. |
| Jan 20, 2010 | Quarterly Results | - |
| Oct 23, 2009 | Quarterly Results | - |
| Jul 21, 2009 | Quarterly Results | - |
| May 18, 2009 | Audited Results, Dividend & Others | To grant of 9,000 stock options, exercisable at par value of Rs 5/- to the Independent Directors of the Co. under "Dr. Reddy's ESOS 2002" & "Dr. Reddy's Employees ADR Stock Option Scheme, 2007". |
| Jan 20, 2009 | Quarterly Results | - |
| Oct 23, 2008 | Quarterly Results & Amalgamation | To consider a Scheme of Amalgamation in terms of which Periecan Pharma Pvt. Ltd, a wholly owned subsidiary of the Company will be amalgamated with Dr. Reddy's Laboratories Ltd. |
| Jul 21, 2008 | Quarterly Results | - |
| May 20, 2008 | Audited Results & Dividend | - |
| Jan 25, 2008 | Quarterly Results | - |
| Oct 24, 2007 | Quarterly Results | - |
| Jul 23, 2007 | Quarterly Results | - |
| May 18, 2007 | Audited Results & Dividend | - |
| Jan 22, 2007 | Quarterly Results | - |
| Oct 27, 2006 | Quarterly Results | - |
| Jul 27, 2006 | Quarterly Results | - |
| May 31, 2006 | Accounts & Dividend | - |
| Jan 24, 2006 | Quarterly Results | - |
| Oct 29, 2005 | Quarterly Results | - |
| Jul 26, 2005 | Quarterly Results | - |
| May 06, 2005 | Accounts & Dividend | - |
| Jan 31, 2005 | Quarterly Results | - |
| Oct 26, 2004 | Quarterly Results | - |
| Jul 27, 2004 | Quarterly Results | - |
| Jan 30, 2004 | Quarterly Results | - |
| Oct 28, 2003 | Quarterly Results | - |
| Jul 31, 2003 | Quarterly Results | - |
| May 30, 2003 | Accounts & Dividend | - |
| Jan 28, 2003 | Quarterly Results | - |
| Oct 24, 2002 | Quarterly Results | - |
| Jul 31, 2002 | Quarterly Results | - |
| Jun 04, 2002 | Accounts & Dividend | - |
| Mar 04, 2002 | Interim Dividend | - |
| Jan 29, 2002 | Quarterly Results | - |
| Oct 31, 2001 | Quarterly, H.Y. Results & I. Dividend | - |
| Jul 31, 2001 | Quarterly Results & Others | Stock Split & Employees Stock Option Plan |
| May 30, 2001 | Accounts & Dividend | - |
| Jan 30, 2001 | Quarterly Results | - |
| Oct 30, 2000 | Quarterly Results | - |
| Jul 28, 2000 | Quarterly Results | - |
| Mar 23, 2000 | Interim Dividend and Issue of ADS | - |
| Mar 06, 2000 | Merger | - |
| Oct 20, 1999 | Quarterly Results | - |
| Jul 29, 1999 | Quarterly Results | - |
| Apr 19, 1999 | Accounts & Dividend | - |
| Jan 30, 1999 | Quarterly Results | - |
| Oct 21, 1998 | Quarterly Results | - |
| Apr 27, 1998 | Accounts & Dividend | - |
| May 17, 1997 | Accounts & Dividend. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Aug 28, 2006 | 1:1 | 2006-08-29 |
25 Jul 2024
Dr Reddy's Labs Q1 Preview: Market share loss in products to drag profits
Indian drugmaker, Dr Reddy's Laboratories is all set to deliver its financial performance for the first quarter of financial year 2024-25 (Q1FY25) on Saturday, July 27, 2024
24 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings
24 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Sale of shares of wholly owned subsidiary company
23 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Update on board meeting
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 ,inter alia, to consider and approve Update on board meeting
18 Jul 2024
Dr. Reddy's Laboratories joins race to bring new GERD drug to India
Dr. Reddy's will market Vonoprazan tablets under its own brand Vono, and it will be available in two strengths, 10 mg and 20 mg
12 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI LODR Regulations, 2015
Disclosure under Regulation 30 of SEBI LODR Regulations, 2015
11 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation in lieu of share certificate(s) reported lost/ misplaced
10 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate(s)
10 Jul 2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call notification for Q1 FY 2025
